JTC Employer Solutions Trustee Ltd
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1875645
ST HELIER, Y9
Position in RXRX
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$43,953
-$14,603 QoQ
Shares Held
14,317
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JTC Employer Solutions Trustee Ltd holds $208,258 across 7 Biotechnology names. RXRX ranks #3 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMCR |
Immunocore Holdings plc
|
2,658 | $80,138 | |
| 2 | PRME |
Prime Medicine, Inc.
|
13,249 | $46,106 | |
| 3 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
14,317 | $43,953 | |
| 4 | MRNA |
Moderna, Inc.
|
300 | $15,240 | |
| 5 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
1,106 | $10,385 | |
| 6 | XBIO |
Xenetic Biosciences, Inc.
|
2,700 | $7,236 | |
| 7 | HRTX |
Heron Therapeutics, Inc. /De/
|
6,500 | $5,200 |
All Filings in RXRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,953 | 14,317 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $58,556 | 14,317 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $69,866 | 14,317 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $12,103 | 2,392 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $12,653 | 2,392 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $16,169 | 2,392 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $15,763 | 2,392 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $17,940 | 2,392 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||